Humoral and cellular immunity to SARS-CoV-2 Ancestral and Omicron BA.5 variants following vaccination in myelofibrosis patients - Top-Institutions - MDSpire

Humoral and cellular immunity to SARS-CoV-2 Ancestral and Omicron BA.5 variants following vaccination in myelofibrosis patients

  • By

  • Ahmad Alcheikh

  • Griffith B. Perkins

  • Phillippa A. Pucar

  • Amelia Cecchin

  • Cheng Sheng Chai

  • Matthew Tunbridge

  • Anouschka Akerman

  • Anupriya Aggarwal

  • Vanessa Milogiannakis

  • Stuart Turville

  • Sharon Allen

  • Pravin Hissaria

  • Tatjana Banovic

  • P. Toby Coates

  • David M. Ross

  • April 10, 2023

  • 0 min

Share

Top Institutions in Hematology

Brief introduction explaining scope and methodology.

  • #1

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, MA

    Key Differentiators

    • Hematology
    • Immunology
    • Infectious Diseases

  • #2

    Fred Hutchinson Cancer Center
    Fred Hutchinson Cancer Center

    Seattle, WA

    Key Differentiators

    • Hematology
    • Immunology
    • Virology

  • #3

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Hematology
    • Oncology
    • Immunotherapy

  • #4

    Peter MacCallum Cancer Centre
    Peter MacCallum Cancer Centre

    Melbourne, VIC

    Key Differentiators

    • Hematology
    • Immunology
    • Infectious Diseases

  • #5

    University of Oxford
    University of Oxford

    Oxford, Oxfordshire

    Key Differentiators

    • Hematology
    • Immunology
    • Vaccine Research

Original Source(s)

Humoral and cellular immunity to SARS-CoV-2 Ancestral and Omicron BA.5 variants following vaccination in myelofibrosis patients

  • by Ahmad Alcheikh, Griffith B. Perkins, Phillippa A. Pucar, Amelia Cecchin, Cheng Sheng Chai, Matthew Tunbridge, Anouschka Akerman, Anupriya Aggarwal, Vanessa Milogiannakis, Stuart Turville, Sharon Allen, Pravin Hissaria, Tatjana Banovic, P. Toby Coates, David M. Ross

  • April 10, 2023

Related Content

Chronic Hepatitis B and COVID-19 Clinical Outcomes in the United States: A Multisite Retrospective Cohort Study

Allogeneic hematopoietic cell transplantation after infection with SARS-CoV-2 during the COVID-19 pandemic: a multicenter retrospective analysis

Impact of Antiphospholipid Antibodies on COVID-19 Severity and Patient Outcomes